fusidic acid has been researched along with nvc-422 in 1 studies
| Studies (fusidic acid) | Trials (fusidic acid) | Recent Studies (post-2010) (fusidic acid) | Studies (nvc-422) | Trials (nvc-422) | Recent Studies (post-2010) (nvc-422) |
|---|---|---|---|---|---|
| 1,742 | 117 | 344 | 12 | 1 | 11 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, M; D'Lima, L; Debabov, D; Friedman, L; Wang, L; Xu, P | 1 |
1 other study(ies) available for fusidic acid and nvc-422
| Article | Year |
|---|---|
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Ciprofloxacin; Diterpenes; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Pseudomonas aeruginosa; Staphylococcus aureus; Taurine | 2012 |